Published in J Virol on November 01, 2002
Antiretroviral pre-exposure prophylaxis prevents vaginal transmission of HIV-1 in humanized BLT mice. PLoS Med (2008) 5.81
HIV enters cells via endocytosis and dynamin-dependent fusion with endosomes. Cell (2009) 4.63
Intrarectal transmission, systemic infection, and CD4+ T cell depletion in humanized mice infected with HIV-1. J Exp Med (2007) 3.75
Predominant mode of human immunodeficiency virus transfer between T cells is mediated by sustained Env-dependent neutralization-resistant virological synapses. J Virol (2007) 3.58
A novel role for phagocytosis-like uptake in herpes simplex virus entry. J Cell Biol (2006) 2.18
Involvement of clathrin-mediated endocytosis in human immunodeficiency virus type 1 entry. J Virol (2005) 2.12
Complementary assays reveal a relationship between HIV-1 uncoating and reverse transcription. Proc Natl Acad Sci U S A (2011) 2.08
Compensatory link between fusion and endocytosis of human immunodeficiency virus type 1 in human CD4 T lymphocytes. J Virol (2004) 2.06
Inhibition of lysosome and proteasome function enhances human immunodeficiency virus type 1 infection. J Virol (2005) 2.05
Early steps of retrovirus replicative cycle. Retrovirology (2004) 1.94
Systemic administration of antiretrovirals prior to exposure prevents rectal and intravenous HIV-1 transmission in humanized BLT mice. PLoS One (2010) 1.88
CD133/prominin-1 is a potential therapeutic target for antibody-drug conjugates in hepatocellular and gastric cancers. Br J Cancer (2008) 1.75
Increased accumulation of intraneuronal amyloid beta in HIV-infected patients. J Neuroimmune Pharmacol (2009) 1.55
A human TRIM5alpha B30.2/SPRY domain mutant gains the ability to restrict and prematurely uncoat B-tropic murine leukemia virus. Virology (2008) 1.52
CD4-independent infection of astrocytes by human immunodeficiency virus type 1: requirement for the human mannose receptor. J Virol (2004) 1.52
Antigenic properties of the human immunodeficiency virus envelope glycoprotein gp120 on virions bound to target cells. PLoS Pathog (2015) 1.50
Genomic editing of the HIV-1 coreceptor CCR5 in adult hematopoietic stem and progenitor cells using zinc finger nucleases. Mol Ther (2013) 1.49
Inhibition of HIV-1 endocytosis allows lipid mixing at the plasma membrane, but not complete fusion. Retrovirology (2011) 1.49
The secreted form of dengue virus nonstructural protein NS1 is endocytosed by hepatocytes and accumulates in late endosomes: implications for viral infectivity. J Virol (2005) 1.43
The HIV envelope but not VSV glycoprotein is capable of mediating HIV latent infection of resting CD4 T cells. PLoS Pathog (2009) 1.42
HIV-1 entry in SupT1-R5, CEM-ss, and primary CD4+ T cells occurs at the plasma membrane and does not require endocytosis. J Virol (2014) 1.14
Analysis of human cell heterokaryons demonstrates that target cell restriction of cyclosporine-resistant human immunodeficiency virus type 1 mutants is genetically dominant. J Virol (2007) 1.13
Virological consequences of early events following cell-cell contact between human immunodeficiency virus type 1-infected and uninfected CD4+ cells. J Virol (2008) 1.06
Receptor-mediated entry by equine infectious anemia virus utilizes a pH-dependent endocytic pathway. J Virol (2005) 1.04
Progress in antiretroviral drug delivery using nanotechnology. Int J Nanomedicine (2010) 1.04
HIV entry: a game of hide-and-fuse? Curr Opin Virol (2013) 1.04
Modified vaccinia virus Ankara triggers type I IFN production in murine conventional dendritic cells via a cGAS/STING-mediated cytosolic DNA-sensing pathway. PLoS Pathog (2014) 1.01
The lipophilic bullet hits the targets: medicinal chemistry of adamantane derivatives. Chem Rev (2013) 0.98
Major histocompatibility complex class II molecules promote human immunodeficiency virus type 1 assembly and budding to late endosomal/multivesicular body compartments. J Virol (2006) 0.98
Lipid-coated nano-calcium-phosphate (LNCP) for gene delivery. Int J Pharm (2010) 0.97
Productive entry of HIV-1 during cell-to-cell transmission via dynamin-dependent endocytosis. J Virol (2013) 0.96
The trinity of the cortical actin in the initiation of HIV-1 infection. Retrovirology (2012) 0.95
Effects of microtubule modulators on HIV-1 infection of transformed and resting CD4 T cells. J Virol (2011) 0.95
Inhibition of endosome-lysosome system acidification enhances porcine circovirus 2 infection of porcine epithelial cells. J Virol (2007) 0.94
Productive infection of human immunodeficiency virus type 1 in dendritic cells requires fusion-mediated viral entry. Virology (2008) 0.93
CD4-independent human immunodeficiency virus infection involves participation of endocytosis and cathepsin B. PLoS One (2011) 0.93
Anti-severe acute respiratory syndrome coronavirus spike antibodies trigger infection of human immune cells via a pH- and cysteine protease-independent FcγR pathway. J Virol (2011) 0.93
Endocytic host cell machinery plays a dominant role in intracellular trafficking of incoming human immunodeficiency virus type 1 in human placental trophoblasts. J Virol (2004) 0.92
Major histocompatibility complex class I downregulation induced by equine herpesvirus type 1 pUL56 is through dynamin-dependent endocytosis. J Virol (2014) 0.92
Macrophages transmit human immunodeficiency virus type 1 products to CD4-negative cells: involvement of matrix metalloproteinase 9. J Virol (2007) 0.92
Enzootic nasal tumor virus envelope requires a very acidic pH for fusion activation and infection. J Virol (2008) 0.91
Mechanisms of viral entry: sneaking in the front door. Protoplasma (2010) 0.88
Induction of innate immune responses by SIV in vivo and in vitro: differential expression and function of RIG-I and MDA5. J Infect Dis (2011) 0.87
Extracellular ATP reduces HIV-1 transfer from immature dendritic cells to CD4+ T lymphocytes. Retrovirology (2008) 0.87
Regulation of hepatitis B virus infection by Rab5, Rab7, and the endolysosomal compartment. J Virol (2013) 0.86
Mechanism for removal of tumor necrosis factor receptor 1 from the cell surface by the adenovirus RIDalpha/beta complex. J Virol (2005) 0.85
Targeting lentiviral vector to specific cell types through surface displayed single chain antibody and fusogenic molecule. Virol J (2010) 0.84
Trans-infection but not infection from within endosomal compartments after cell-to-cell HIV-1 transfer to CD4+ T cells. J Biol Chem (2012) 0.83
Infection of XC cells by MLVs and Ebola virus is endosome-dependent but acidification-independent. PLoS One (2011) 0.83
Endocytosis-mediated HIV-1 entry and its significance in the elusive behavior of the virus in astrocytes. Virology (2014) 0.82
Generation and characterization of a stable cell population releasing fluorescent HIV-1-based Virus Like Particles in an inducible way. BMC Biotechnol (2006) 0.81
Imaging real-time HIV-1 virion fusion with FRET-based biosensors. Sci Rep (2015) 0.80
Characteristics of the cellular receptor influence the intracellular fate and efficiency of virus infection. J Virol (2013) 0.80
Antiviral peptide nanocomplexes as a potential therapeutic modality for HIV/HCV co-infection. Biomaterials (2013) 0.79
Reversible and efficient activation of HIV-1 cell entry by a tyrosine-sulfated peptide dissects endocytic entry and inhibitor mechanisms. J Virol (2014) 0.79
Complement opsonization of HIV-1 results in a different intracellular processing pattern and enhanced MHC class I presentation by dendritic cells. Eur J Immunol (2013) 0.79
Retrovirus entry by endocytosis and cathepsin proteases. Adv Virol (2012) 0.79
Molecular determinants of the ratio of inert to infectious virus particles. Prog Mol Biol Transl Sci (2014) 0.79
Immune activation and the role of TLRs and TLR agonists in the pathogenesis of HIV-1 infection in the humanized mouse model. J Infect Dis (2013) 0.78
Unperturbed posttranscriptional regulatory Rev protein function and HIV-1 replication in astrocytes. PLoS One (2014) 0.78
Receptor-Targeted Nipah Virus Glycoproteins Improve Cell-Type Selective Gene Delivery and Reveal a Preference for Membrane-Proximal Cell Attachment. PLoS Pathog (2016) 0.77
Dynamic electrophoretic fingerprinting of the HIV-1 envelope glycoprotein. Retrovirology (2013) 0.77
Abrogation of contaminating RNA activity in HIV-1 Gag VLPs. Virol J (2011) 0.77
Endocytosis of human immunodeficiency virus 1 (HIV-1) in astrocytes: a fiery path to its destination. Microb Pathog (2014) 0.76
Local drug and gene delivery through microbubbles and ultrasound. Neth Heart J (2004) 0.76
Receptor Crosslinking in Drug Delivery: Detour to the Lysosome? Mol Ther (2015) 0.75
The Effect of Chloroquine on Immune Activation and Interferon Signatures Associated with HIV-1. AIDS Res Hum Retroviruses (2016) 0.75
Dengue virus compartmentalization during antibody-enhanced infection. Sci Rep (2017) 0.75
Poly(lactic-co-glycolic) Acid-Chitosan Dual Loaded Nanoparticles for Antiretroviral Nanoformulations. J Drug Deliv (2016) 0.75
Intracellular trafficking of hybrid gene delivery vectors. J Control Release (2015) 0.75
Cleavage of hemagglutinin-bearing lentiviral pseudotypes and their use in the study of influenza virus persistence. PLoS One (2014) 0.75
Calcitonin gene-related peptide induces HIV-1 proteasomal degradation in mucosal Langerhans cells. J Virol (2017) 0.75
Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu Rev Biochem (2000) 19.03
Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu Rev Immunol (1999) 13.55
Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene. J Virol (1992) 12.89
Commentary. Lysosomotropic agents. Biochem Pharmacol (1974) 12.28
Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1. J Virol (1998) 10.94
Acidification of the endocytic and exocytic pathways. Annu Rev Biochem (1986) 10.90
Virus-cell and cell-cell fusion. Annu Rev Cell Dev Biol (1996) 5.83
Changes in growth properties on passage in tissue culture of viruses derived from infectious molecular clones of HIV-1LAI, HIV-1MAL, and HIV-1ELI. Virology (1991) 5.54
Fusion mutants of the influenza virus hemagglutinin glycoprotein. Cell (1985) 4.84
Combination therapy for malaria in Africa: hype or hope? Bull World Health Organ (2003) 3.83
Bafilomycins and concanamycins as inhibitors of V-ATPases and P-ATPases. J Exp Biol (1997) 3.35
Membrane raft microdomains mediate lateral assemblies required for HIV-1 infection. EMBO Rep (2000) 3.23
CD4, CXCR-4, and CCR-5 dependencies for infections by primary patient and laboratory-adapted isolates of human immunodeficiency virus type 1. J Virol (1997) 3.04
Inhibitory effect of modified bafilomycins and concanamycins on P- and V-type adenosinetriphosphatases. Biochemistry (1993) 2.86
Cytosolic Gag p24 as an index of productive entry of human immunodeficiency virus type 1. J Virol (1998) 2.82
Beyond receptor expression: the influence of receptor conformation, density, and affinity in HIV-1 infection. Virology (2000) 2.60
Endocytic entry of HIV-1. Curr Biol (2000) 2.08
Human immunodeficiency virus type 1 Nef functions at the level of virus entry by enhancing cytoplasmic delivery of virions. J Virol (2001) 2.06
Involvement of the vacuolar H(+)-ATPase in animal virus entry. J Gen Virol (1994) 2.06
Mechanisms of enveloped virus entry into cells. Mol Biol Med (1990) 1.87
CCR5, CXCR4, and CD4 are clustered and closely apposed on microvilli of human macrophages and T cells. J Virol (2001) 1.66
Regulation of organelle acidity. J Gen Physiol (2001) 1.63
Prevention and early treatment of influenza in healthy adults. Vaccine (2000) 1.58
Infectivity enhancement by HIV-1 Nef is dependent on the pathway of virus entry: implications for HIV-based gene transfer systems. Virology (1998) 1.49
Clinical pharmacokinetics and metabolism of chloroquine. Focus on recent advancements. Clin Pharmacokinet (1996) 1.42
Updated treatment for influenza A and B. Am Fam Physician (2000) 1.42
Incidence of amantadine-resistant influenza A viruses in sentinel surveillance sites and nursing homes in Niigata, Japan. Microbiol Immunol (2000) 1.25
Differentiation of acid-pH-dependent and -nondependent entry pathways for mouse hepatitis virus. Virology (1991) 1.21
Effects of malaria infection in human immunodeficiency virus type 1-infected Ugandan children. Pediatr Infect Dis J (1997) 1.18
Beneficial effects of amantadine on L-dopa-induced dyskinesias in Parkinson's disease. Mov Disord (2000) 1.17
Managing influenza: amantadine, rimantadine and beyond. Int J Clin Pract (2001) 1.11
Clinical pharmacokinetics of amantadine hydrochloride. Clin Pharmacokinet (1988) 1.09
Malaria chemoprophylaxis in the age of drug resistance. I. Currently recommended drug regimens. Clin Infect Dis (2001) 1.09
Chemistry and structure activity relationships of bafilomycin A1, a potent and selective inhibitor of the vacuolar H+-ATPase. Curr Med Chem (1999) 1.07
The pharmacokinetics of three multiple dose regimens of chloroquine: implications for malaria chemoprophylaxis. Br J Clin Pharmacol (1995) 1.02
Isolation of amantadine-resistant influenza a viruses (H3N2) from patients following administration of amantadine in Japan. J Clin Microbiol (2001) 0.93
In vitro fusion of endocytic vesicles: effects of reagents that alter endosomal pH. J Cell Biochem (1996) 0.92
Retrovirus vector-mediated transfer of functional HIV-1 regulatory genes. AIDS Res Hum Retroviruses (1994) 0.91
Hydroxychloroquine overdose: toxicokinetics and management. J Toxicol Clin Toxicol (1999) 0.90
Review of the prevalence of malaria in Zimbabwe with specific reference to parasite drug resistance (1984-96). Trans R Soc Trop Med Hyg (2000) 0.88
Pharmacological treatment of Parkinson's disease. Postgrad Med J (2000) 0.87
Chloroquine poisoning in a child. Ann Emerg Med (1990) 0.84
Antiviral agents for treating influenza. Cleve Clin J Med (2000) 0.83
Management of HIV-infected pregnant patients in malaria-endemic areas: therapeutic and safety considerations in concomitant use of antiretroviral and antimalarial agents. Clin Ther (1999) 0.83
Macrophage cytoplasmic vesicle pH gradients and vacuolar H+-ATPase activities relative to virus infection. J Leukoc Biol (1998) 0.82
Retrovirus-mediated transfer and long-term expression of HIV type 1 tat gene in murine hematopoietic tissues. AIDS Res Hum Retroviruses (1994) 0.80
Antimalarial chemoprophylaxis in infants and children. Paediatr Drugs (2001) 0.79
Antiretroviral pre-exposure prophylaxis prevents vaginal transmission of HIV-1 in humanized BLT mice. PLoS Med (2008) 5.81
Genome sequencing and analysis of the biomass-degrading fungus Trichoderma reesei (syn. Hypocrea jecorina). Nat Biotechnol (2008) 5.38
Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1. Nat Med (2006) 5.36
Intrarectal transmission, systemic infection, and CD4+ T cell depletion in humanized mice infected with HIV-1. J Exp Med (2007) 3.75
Gain of miR-151 on chromosome 8q24.3 facilitates tumour cell migration and spreading through downregulating RhoGDIA. Nat Cell Biol (2010) 3.27
Transcriptional regulation of biomass-degrading enzymes in the filamentous fungus Trichoderma reesei. J Biol Chem (2003) 2.77
Plant hormone jasmonate prioritizes defense over growth by interfering with gibberellin signaling cascade. Proc Natl Acad Sci U S A (2012) 2.34
Generation of HIV latency in humanized BLT mice. J Virol (2011) 2.20
Inhibition of lysosome and proteasome function enhances human immunodeficiency virus type 1 infection. J Virol (2005) 2.05
Dengue fever in humanized NOD/SCID mice. J Virol (2005) 1.96
HIV-1 Nef: at the crossroads. Retrovirology (2008) 1.88
MicroRNA-125b suppressesed human liver cancer cell proliferation and metastasis by directly targeting oncogene LIN28B2. Hepatology (2010) 1.88
Systemic administration of antiretrovirals prior to exposure prevents rectal and intravenous HIV-1 transmission in humanized BLT mice. PLoS One (2010) 1.88
Identification of open reading frames unique to a select agent: Ralstonia solanacearum race 3 biovar 2. Mol Plant Microbe Interact (2006) 1.77
Granulocyte-colony stimulating factor reactivates human cytomegalovirus in a latently infected humanized mouse model. Cell Host Microbe (2010) 1.77
Production of transgenic rats by lentiviral transduction of male germ-line stem cells. Proc Natl Acad Sci U S A (2002) 1.68
{2,2'-[1,1'-(Ethyl-enedioxy-dinitrilo)diethyl-idyne]di-1-naphtholato}nickel(II). Acta Crystallogr Sect E Struct Rep Online (2009) 1.67
{2,2'-[1,1'-(Ethyl-enedioxy-dinitrilo)diethyl-idyne]di-1-naphtholato}copper(II). Acta Crystallogr Sect E Struct Rep Online (2009) 1.66
Evaluation of biocompatibility of polypyrrole in vitro and in vivo. J Biomed Mater Res A (2004) 1.59
Real-time detection and continuous monitoring of ER stress in vitro and in vivo by ES-TRAP: evidence for systemic, transient ER stress during endotoxemia. Nucleic Acids Res (2006) 1.55
Involvement of selective reactive oxygen species upstream of proapoptotic branches of unfolded protein response. J Biol Chem (2007) 1.45
Activation of the Akt-NF-kappaB pathway by subtilase cytotoxin through the ATF6 branch of the unfolded protein response. J Immunol (2009) 1.44
Induction of apoptosis by cigarette smoke via ROS-dependent endoplasmic reticulum stress and CCAAT/enhancer-binding protein-homologous protein (CHOP). Free Radic Biol Med (2008) 1.43
Nef: agent of cell subversion. Microbes Infect (2002) 1.41
Bis{(E)-4-bromo-2-[(2-chloro-3-pyrid-yl)imino-meth-yl]phenolato-κN,O}copper(II). Acta Crystallogr Sect E Struct Rep Online (2009) 1.41
Dynamic evolution of the human immunodeficiency virus type 1 pathogenic factor, Nef. J Virol (2006) 1.41
Novel humanized murine models for HIV research. Curr HIV/AIDS Rep (2009) 1.40
Behavior of Ralstonia solanacearum Race 3 Biovar 2 During Latent and Active Infection of Geranium. Phytopathology (2005) 1.39
Hypoxia-inducible microRNA-210 augments the metastatic potential of tumor cells by targeting vacuole membrane protein 1 in hepatocellular carcinoma. Hepatology (2011) 1.36
Molecular mechanisms of autosomal recessive hypercholesterolemia. Hum Mol Genet (2002) 1.33
Recovery and maintenance of nephrin expression in cultured podocytes and identification of HGF as a repressor of nephrin. Am J Physiol Renal Physiol (2007) 1.31
High levels of dioxin-like potential in cigarette smoke evidenced by in vitro and in vivo biosensing. Cancer Res (2006) 1.30
Human breast milk and antiretrovirals dramatically reduce oral HIV-1 transmission in BLT humanized mice. PLoS Pathog (2012) 1.30
Experimental infection of NOD/SCID mice reconstituted with human CD34+ cells with Epstein-Barr virus. J Virol (2004) 1.24
Human dendritic cell subsets in NOD/SCID mice engrafted with CD34+ hematopoietic progenitors. Blood (2003) 1.23
Immune reconstitution of the female reproductive tract of humanized BLT mice and their susceptibility to human immunodeficiency virus infection. J Reprod Immunol (2011) 1.22
Bacterial effector activates jasmonate signaling by directly targeting JAZ transcriptional repressors. PLoS Pathog (2013) 1.18
Bone marrow cells contribute to regeneration of damaged glomerular endothelial cells. Kidney Int (2005) 1.16
Mucosal HIV-1 transmission and prevention strategies in BLT humanized mice. Trends Microbiol (2012) 1.15
Development and activation of human dendritic cells in vivo in a xenograft model of human hematopoiesis. Stem Cells (2005) 1.14
Nef functions in BLT mice to enhance HIV-1 replication and deplete CD4+CD8+ thymocytes. Retrovirology (2012) 1.14
The role of cytosolic alpha-glucan phosphorylase in maltose metabolism and the comparison of amylomaltase in Arabidopsis and Escherichia coli. Plant Physiol (2006) 1.14
Dog sciatic nerve regeneration across a 30-mm defect bridged by a chitosan/PGA artificial nerve graft. Brain (2005) 1.12
Major depression in Kunming: prevalence, correlates and co-morbidity in a south-western city of China. J Affect Disord (2008) 1.12
Latent HIV-1 infection of resting CD4⁺ T cells in the humanized Rag2⁻/⁻ γc⁻/⁻ mouse. J Virol (2011) 1.11
Selective abrogation of BiP/GRP78 blunts activation of NF-κB through the ATF6 branch of the UPR: involvement of C/EBPβ and mTOR-dependent dephosphorylation of Akt. Mol Cell Biol (2011) 1.10
A hydrophobic binding surface on the human immunodeficiency virus type 1 Nef core is critical for association with p21-activated kinase 2. J Virol (2006) 1.10
Transcriptional suppression of nephrin in podocytes by macrophages: roles of inflammatory cytokines and involvement of the PI3K/Akt pathway. FEBS Lett (2007) 1.07
Alkaline phosphatase vs luciferase as secreted reporter molecules in vivo. Anal Biochem (2005) 1.07
Suppression of NF-kappaB by cyclosporin a and tacrolimus (FK506) via induction of the C/EBP family: implication for unfolded protein response. J Immunol (2009) 1.05
Mechanisms of HIV-1 Nef function and intracellular signaling. J Neuroimmune Pharmacol (2011) 1.04
Macrophages sustain HIV replication in vivo independently of T cells. J Clin Invest (2016) 1.04
2,2'-{1,1'-[Butane-1,4-diyl-bis(oxy-nitrilo)]di-ethylidyne}di-1-naphthol. Acta Crystallogr Sect E Struct Rep Online (2009) 1.03
Acquisition of anergy to proinflammatory cytokines in nonimmune cells through endoplasmic reticulum stress response: a mechanism for subsidence of inflammation. J Immunol (2009) 1.03
Effect of high glucose on nitric oxide production and endothelial nitric oxide synthase protein expression in human glomerular endothelial cells. Nephron Exp Nephrol (2003) 1.02
The protective effects of Achyranthes bidentata polypeptides in an experimental model of mouse sciatic nerve crush injury. Brain Res Bull (2010) 1.01
Up-regulation of connexin43 in glomerular podocytes in response to injury. Am J Pathol (2002) 1.01
In vivo analysis of Nef function. Curr HIV Res (2003) 1.00
HIV restriction by APOBEC3 in humanized mice. PLoS Pathog (2013) 1.00
Role of Nef in HIV-1 replication and pathogenesis. Adv Pharmacol (2007) 1.00
Cellular defense against H2O2-induced apoptosis via MAP kinase-MKP-1 pathway. Free Radic Biol Med (2004) 0.99
Smad4 is essential for down-regulation of E-cadherin induced by TGF-beta in pancreatic cancer cell line PANC-1. J Biochem (2007) 0.99
Rapid, transient induction of ER stress in the liver and kidney after acute exposure to heavy metal: evidence from transgenic sensor mice. FEBS Lett (2007) 0.99
Negative feedback control of jasmonate signaling by an alternative splice variant of JAZ10. Plant Physiol (2013) 0.99
ER stress disrupts Ca2+-signaling complexes and Ca2+ regulation in secretory and muscle cells from PERK-knockout mice. J Cell Sci (2005) 0.98
Structural characterization of a water-soluble beta-D-glucan from fruiting bodies of Agaricus blazei Murr. Carbohydr Res (2002) 0.98
Bis{(E)-4-chloro-2-[(2-chloro-3-pyrid-yl)imino-methyl-κN]phenolato-κO}copper(II). Acta Crystallogr Sect E Struct Rep Online (2009) 0.97
ER stress depresses NF-kappaB activation in mesangial cells through preferential induction of C/EBP beta. J Am Soc Nephrol (2009) 0.97
Cryptopatches are essential for the development of human GALT. Cell Rep (2013) 0.96
Bone marrow-derived cells contribute to contractile dysfunction in endotoxic shock. Am J Physiol Heart Circ Physiol (2004) 0.96
Secreted protein-based reporter systems for monitoring inflammatory events: critical interference by endoplasmic reticulum stress. J Immunol Methods (2006) 0.96
Suppression of cytokine responses by indomethacin in podocytes: a mechanism through induction of unfolded protein response. Am J Physiol Renal Physiol (2008) 0.96
Real-time observation of glomerular hemodynamic changes in diabetic rats: effects of insulin and ARB. Kidney Int (2004) 0.95
Connexin43 hemichannels contribute to cadmium-induced oxidative stress and cell injury. Antioxid Redox Signal (2011) 0.95
Intraocular expression of endostatin reduces VEGF-induced retinal vascular permeability, neovascularization, and retinal detachment. FASEB J (2003) 0.94
HLA-B*57 elite suppressor and chronic progressor HIV-1 isolates replicate vigorously and cause CD4+ T cell depletion in humanized BLT mice. J Virol (2014) 0.94
Gap junction-mediated intercellular communication between dendritic cells (DCs) is required for effective activation of DCs. J Immunol (2006) 0.94
Continuous, noninvasive monitoring of local microscopic inflammation using a genetically engineered cell-based biosensor. Lab Invest (2005) 0.93
Rectal transmission of transmitted/founder HIV-1 is efficiently prevented by topical 1% tenofovir in BLT humanized mice. PLoS One (2013) 0.93
Suppression of cytokine response by GATA inhibitor K-7174 via unfolded protein response. Biochem Biophys Res Commun (2007) 0.93
Suppression of nephrin expression by TNF-alpha via interfering with the cAMP-retinoic acid receptor pathway. Am J Physiol Renal Physiol (2010) 0.92
DRESSA: biosensing of dioxin and dioxin-like chemicals using secreted alkaline phosphatase. Anal Biochem (2004) 0.92
Activation of p21-activated kinase 2 by human immunodeficiency virus type 1 Nef induces merlin phosphorylation. J Virol (2005) 0.92
Transcription factor-dependent nuclear localization of a transcriptional repressor in jasmonate hormone signaling. Proc Natl Acad Sci U S A (2012) 0.92
CD4 and MHC-I downregulation are conserved in primary HIV-1 Nef alleles from brain and lymphoid tissues, but Pak2 activation is highly variable. Virology (2006) 0.92
Involvement of hypoxia-triggered endoplasmic reticulum stress in outlet obstruction-induced apoptosis in the urinary bladder. Lab Invest (2008) 0.92
Inefficient vaginal transmission of tenofovir-resistant HIV-1. J Virol (2012) 0.91
Different expression patterns of Bcl-2, Bcl-xl, and Bax proteins after sublethal forebrain ischemia in C57Black/Crj6 mouse striatum. Stroke (2003) 0.90
Blunted activation of NF-kappaB and NF-kappaB-dependent gene expression by geranylgeranylacetone: involvement of unfolded protein response. Biochem Biophys Res Commun (2007) 0.90
Downregulation of gap junction expression and function by endoplasmic reticulum stress. J Cell Biochem (2009) 0.90
Geranylgeranylacetone, an inducer of the 70-kDa heat shock protein (HSP70), elicits unfolded protein response and coordinates cellular fate independently of HSP70. Mol Pharmacol (2007) 0.89
Functional characterization of the human immunodeficiency virus type 1 Nef acidic domain. J Virol (2008) 0.89
Real-time monitoring of mesangial cell-macrophage cross-talk using SEAP in vitro and ex vivo. Kidney Int (2005) 0.89